From: From fiction to science: clinical potentials and regulatory considerations of gene editing
 | CRISPR | ZFN | TALEN | Meganuclease |
---|---|---|---|---|
Binding principle | RNA-DNA | Protein–DNA | Protein–DNA | Protein–DNA |
Feasibility | Easy | Difficult | Difficult | Difficult |
Construction | 20 nucleotide sgRNA sequence per target site | Engineering new proteins for every target site | Engineering new proteins for every target site | Engineering new proteins for every target site |
Ease of multiplexing | Easy | Difficult | Difficult | Difficult |